Category : Search result: obesity America


US Withdraws from 66 International Organisations Under Trump

President Trump pulls the US out of 66 UN and global bodies, including climate and health groups, while proposing a massive $1.5 trillion defence budget. Analysts warn of a retreat from multilateralism. Read the full analysis.

Causes of High Blood Pressure in Children Explained

High blood pressure is rising among Indian children. Learn the 5 main causes, from obesity to family history, and discover crucial prevention strategies to protect your child's heart health.

UK Enforces 9 PM Watershed Ban on Junk Food Advertising

The UK government has implemented a landmark ban on junk food ads before 9 PM on TV and online. This world-leading policy aims to remove billions of calories from children's diets and tackle obesity. Learn about the details and potential impact.

US Captures Maduro, Trump Vows To Run Venezuela

US military seizes Venezuela's President Maduro. Trump declares America 'in charge', sparking global fears of further interventions in Latin America. Read the full analysis.

Latin America's Split Reaction to US Action on Maduro

The US seizure of Venezuela's Nicolás Maduro sparks condemnation and applause across Latin America, highlighting regional divisions over intervention and authoritarian rule. Read the full analysis.

Childhood Hypertension Doubles in UK: A Silent Epidemic

Cases of high blood pressure in UK children have doubled, driven by obesity and poor diet. This 'silent killer' shows no early symptoms but can cause permanent damage. Learn the signs and how parents can act.

Latin America's New Democratic Dawn in 2026

Historian Enrique Krauze analyses Latin America's cyclical struggle for democracy, from 19th-century ideals to 2026's populist retreat and Venezuela's pivotal moment. Explore the region's resilient fight for freedom.

Indian Pharma Firms Eye Licensing Deals for Obesity Drugs

As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.

Weight-Loss Pill Race in 2026: Lilly Leads Novo Nordisk

Novo Nordisk and Eli Lilly to launch oral GLP-1 drugs in 2026. Despite Novo's head start, analysts predict Lilly's market leadership in obesity and diabetes treatments will persist for years. Explore the details.

UAE Forges Strategic Partnerships in Latin America

The UAE is expanding its strategic partnerships and unlocking significant investment opportunities across Latin America, focusing on trade, sustainability, and infrastructure. Discover the key agreements and future prospects.

Page 1 of 4